Harrison Cash

849 total citations
9 papers, 693 citations indexed

About

Harrison Cash is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Harrison Cash has authored 9 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Harrison Cash's work include Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Harrison Cash is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Harrison Cash collaborates with scholars based in United States. Harrison Cash's co-authors include Clint Allen, Carter Van Waes, Ellen Moore, Paúl E. Clavijo, Ruth J. Davis, Edwin R. Sánchez, Sonia M. Najjar, Lance A. Stechschulte, Terry D. Hinds and Jay Friedman and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Endocrinology.

In The Last Decade

Harrison Cash

9 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harrison Cash United States 9 363 330 233 75 64 9 693
Lars‐Oliver Tykocinski Germany 18 443 1.2× 130 0.4× 269 1.2× 106 1.4× 50 0.8× 22 802
Imran S. Khan United States 12 399 1.1× 171 0.5× 315 1.4× 164 2.2× 86 1.3× 16 868
Natalie V. Singer United States 10 375 1.0× 154 0.5× 251 1.1× 36 0.5× 30 0.5× 18 798
Larry Wong United States 9 413 1.1× 246 0.7× 157 0.7× 20 0.3× 42 0.7× 10 698
Sonja Schallenberg Germany 14 808 2.2× 222 0.7× 223 1.0× 21 0.3× 52 0.8× 18 1.1k
Duncan M. Morgan United States 11 374 1.0× 248 0.8× 324 1.4× 22 0.3× 163 2.5× 18 890
Vidalba Rocher-Ros United Kingdom 3 337 0.9× 137 0.4× 222 1.0× 17 0.2× 57 0.9× 4 674
Wen-I Yeh United States 11 504 1.4× 232 0.7× 104 0.4× 33 0.4× 39 0.6× 24 725
Beth Lucas United Kingdom 14 558 1.5× 257 0.8× 149 0.6× 64 0.9× 40 0.6× 18 757
Marina Vignoli Italy 12 274 0.8× 182 0.6× 165 0.7× 16 0.2× 20 0.3× 22 640

Countries citing papers authored by Harrison Cash

Since Specialization
Citations

This map shows the geographic impact of Harrison Cash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harrison Cash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harrison Cash more than expected).

Fields of papers citing papers by Harrison Cash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harrison Cash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harrison Cash. The network helps show where Harrison Cash may publish in the future.

Co-authorship network of co-authors of Harrison Cash

This figure shows the co-authorship network connecting the top 25 collaborators of Harrison Cash. A scholar is included among the top collaborators of Harrison Cash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harrison Cash. Harrison Cash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Davis, Ruth J., Ellen Moore, Paúl E. Clavijo, et al.. (2017). Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. Cancer Research. 77(10). 2607–2619. 178 indexed citations
2.
Morisada, Megan V., Ellen Moore, Rachel Hodge, et al.. (2017). Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer. Oral Oncology. 71. 87–94. 24 indexed citations
3.
Moore, Ellen, Harrison Cash, Ravindra Uppaluri, et al.. (2016). Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers. Cancer Immunology Research. 4(7). 611–620. 81 indexed citations
4.
Moore, Ellen, Paúl E. Clavijo, Ruth J. Davis, et al.. (2016). Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade. Cancer Immunology Research. 4(12). 1061–1071. 123 indexed citations
5.
Cash, Harrison, et al.. (2016). Pools of programmed death‐ligand within the oral cavity tumor microenvironment: Variable alteration by targeted therapies. Head & Neck. 38(8). 1176–1186. 18 indexed citations
6.
7.
Hinds, Terry D., Lance A. Stechschulte, Harrison Cash, et al.. (2011). Protein Phosphatase 5 Mediates Lipid Metabolism through Reciprocal Control of Glucocorticoid Receptor and Peroxisome Proliferator-activated Receptor-γ (PPARγ). Journal of Biological Chemistry. 286(50). 42911–42922. 73 indexed citations
8.
Hinds, Terry D., Sadeesh K. Ramakrishnan, Harrison Cash, et al.. (2010). Discovery of Glucocorticoid Receptor-β in Mice with a Role in Metabolism. Molecular Endocrinology. 24(9). 1715–1727. 107 indexed citations
9.
Warrier, Manya, Terry D. Hinds, Harrison Cash, et al.. (2010). Susceptibility to Diet-Induced Hepatic Steatosis and Glucocorticoid Resistance in FK506-Binding Protein 52-Deficient Mice. Endocrinology. 151(7). 3225–3236. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026